Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 9;127(8):1497–1506. doi: 10.1038/s41416-022-01941-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to Springer Nature Limited 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PMC Copyright notice

Fig. 1 — Forty-eight patients were enrolled on the trial. All patients started re-induction chemotherapy. Seventeen patients discontinued therapy prior to concurrent chemotherapy and re-irradiation. Thirty-one patients started chemotherapy and re-irradiation. Three patients were treated on the AXX arm which subsequently closed due to poor accrual. Twenty-eight patients started AFHX. All twenty-eight patients completed re-irradiation with concurrent chemotherapy.